Delivery Order SPE2DB22D3501-SPE2DB25FXA02
- Not listed
- The Defense Logistics Agency awarded a $6,014.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The award was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $11,265.34 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product used in clinical settings. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery...
- The Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,793.37 for INFUVITE Adult Vial 10ML, a parenteral nutrition product used in clinical settings. This firm fixed-price delivery order, issued on August 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INFUVITE ADULT VIAL 10ML, an intravenous nutritional supplement product, valued at $11.5K. This non-competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,214.08 for Infuvite Adult 10ML (5 units) by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Infuvite Adult Bulk Vial 100ML, a nutritional supplement product. This firm fixed-price delivery order, valued at $11,687.94, is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,435.68 to AmerisourceBergen Drug Corp for Infuvite Pediatric Bulk Vial 50ML, a pharmaceutical product for pediatric intravenous nutrition support. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $14,316.75 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a pharmaceutical product for medical supply support. The contract, awarded on August 20, 2025, carries a firm fixed price structure with an ultimate completion date of August 21, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $19,211.16 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vial 5ML, a pediatric parenteral nutrition product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without a set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order, valued at $2,416.00, is for the delivery of Infuvite Adult 10 mL 5S, a pharmaceutical product, to support military treatment programs and facilities. The delivery order was issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXA02Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,017.91 to AmerisourceBergen Drug Corp for Infuvite Adult Vial 10ML, a parenteral nutrition product used in clinical and military healthcare settings. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of August 26, 2025. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor agreement enables the contractor to supply comprehensive pharmaceutical and medical products to support Defense Health Agency and military healthcare programs globally. AmerisourceBergen's role as a major pharmaceutical distributor positions it as a critical supplier for federal medical procurement, with its contract portfolio demonstrating consistent capability to fulfill competitive medical supply requirements across diverse therapeutic domains and customer bases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/25/25 |